Long Non-Coding RNA OIP5-AS1 Knockdown Enhances CDDP Sensitivity in Osteosarcoma via miR-377-3p/FOSL2 Axis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long Non-Coding RNA OIP5-AS1 Knockdown Enhances CDDP Sensitivity in Osteosarcoma via miR-377-3p/FOSL2 Axis
Authors
Keywords
-
Journal
OncoTargets and Therapy
Volume Volume 13, Issue -, Pages 3853-3866
Publisher
Informa UK Limited
Online
2020-05-07
DOI
10.2147/ott.s232918
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of lncRNA ANRIL knockdown on proliferation and cisplatin chemoresistance of osteosarcoma cells in vitro
- (2019) Guowei Li et al. PATHOLOGY RESEARCH AND PRACTICE
- LncRNA OIP5-AS1 Promotes the Proliferation of Hemangioma Vascular Endothelial Cells via Regulating miR-195-5p/NOB1 Axis
- (2019) Jiayu Zhang et al. Frontiers in Pharmacology
- LncRNA UCA1 mediates resistance to cisplatin by regulating miR-143/FOSL2 signaling pathway in Ovarian Cancer
- (2019) Zewu Li et al. Molecular Therapy-Nucleic Acids
- MicroRNA‐377 exerts a potent suppressive role in osteosarcoma through the involvement of the histone acetyltransferase 1‐mediated Wnt axis
- (2019) Peng Xia et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis
- (2019) Minghe Li et al. BIOMEDICINE & PHARMACOTHERAPY
- miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1
- (2018) Haibin Yan et al. ANTI-CANCER DRUGS
- miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2
- (2018) Xiangran Sun et al. Scientific Reports
- Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223
- (2018) Jian Dai et al. BIOMEDICINE & PHARMACOTHERAPY
- Fibronectin-1 modulated by the long noncoding RNA OIP5-AS1/miR-200b-3p axis contributes to doxorubicin resistance of osteosarcoma cells
- (2018) Zhu Kun-Peng et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410
- (2018) Wei-Li Sun et al. BIOSCIENCE REPORTS
- Long noncoding RNA OIP5‐AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR‐340‐5p
- (2018) Lei Song et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- LncRNA OIP5-AS1 predicts poor prognosis and regulates cell proliferation and apoptosis in bladder cancer
- (2018) Yang Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Silencing LPAATβ inhibits tumor growth of cisplatin-resistant human osteosarcoma in vivo and in vitro
- (2016) Lei Song et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- LncRNA: A link between RNA and cancer
- (2014) Guodong Yang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST
- (2014) Yong Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MiR-34c inhibits osteosarcoma metastasis and chemoresistance
- (2014) Meng Xu et al. MEDICAL ONCOLOGY
- MicroRNAs in Cancer
- (2009) Ramiro Garzon et al. Annual Review of Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started